

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | drug catabolic process (GO:0042737) | 9.93218519 |
| 2 | epoxygenase P450 pathway (GO:0019373) | 9.87871560 |
| 3 | complement activation, alternative pathway (GO:0006957) | 9.23655002 |
| 4 | L-phenylalanine catabolic process (GO:0006559) | 8.15990895 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 8.15990895 |
| 6 | regulation of fibrinolysis (GO:0051917) | 8.02564897 |
| 7 | regulation of protein activation cascade (GO:2000257) | 7.96343065 |
| 8 | glyoxylate metabolic process (GO:0046487) | 7.62919496 |
| 9 | regulation of complement activation (GO:0030449) | 7.57900386 |
| 10 | negative regulation of fibrinolysis (GO:0051918) | 7.53341097 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 7.44142256 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.44142256 |
| 13 | ethanol oxidation (GO:0006069) | 7.26631240 |
| 14 | urea metabolic process (GO:0019627) | 6.93440816 |
| 15 | drug metabolic process (GO:0017144) | 6.66713874 |
| 16 | cellular glucuronidation (GO:0052695) | 6.47658024 |
| 17 | oxidative demethylation (GO:0070989) | 6.32416078 |
| 18 | nitrogen cycle metabolic process (GO:0071941) | 6.31240782 |
| 19 | fibrinolysis (GO:0042730) | 6.21181825 |
| 20 | protein carboxylation (GO:0018214) | 6.16716932 |
| 21 | peptidyl-glutamic acid carboxylation (GO:0017187) | 6.16716932 |
| 22 | glucuronate metabolic process (GO:0019585) | 6.14036220 |
| 23 | uronic acid metabolic process (GO:0006063) | 6.14036220 |
| 24 | aromatic amino acid family catabolic process (GO:0009074) | 6.08207662 |
| 25 | bile acid biosynthetic process (GO:0006699) | 5.89426041 |
| 26 | ethanol metabolic process (GO:0006067) | 5.80426780 |
| 27 | blood coagulation, intrinsic pathway (GO:0007597) | 5.77988060 |
| 28 | imidazole-containing compound metabolic process (GO:0052803) | 5.75859219 |
| 29 | urea cycle (GO:0000050) | 5.75270999 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 5.58778760 |
| 31 | protein activation cascade (GO:0072376) | 5.40075508 |
| 32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.36886996 |
| 33 | bile acid metabolic process (GO:0008206) | 5.33436907 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 5.33017020 |
| 35 | negative regulation of cholesterol transport (GO:0032375) | 5.23620353 |
| 36 | negative regulation of sterol transport (GO:0032372) | 5.23620353 |
| 37 | complement activation (GO:0006956) | 5.23525588 |
| 38 | opsonization (GO:0008228) | 5.18348520 |
| 39 | bile acid and bile salt transport (GO:0015721) | 5.10413486 |
| 40 | complement activation, classical pathway (GO:0006958) | 5.08699099 |
| 41 | regulation of plasminogen activation (GO:0010755) | 5.05178093 |
| 42 | S-adenosylmethionine metabolic process (GO:0046500) | 4.95152409 |
| 43 | glycine metabolic process (GO:0006544) | 4.90643509 |
| 44 | tyrosine metabolic process (GO:0006570) | 4.89723607 |
| 45 | phenylpropanoid metabolic process (GO:0009698) | 4.88959238 |
| 46 | regulation of humoral immune response (GO:0002920) | 4.79914193 |
| 47 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 4.76926893 |
| 48 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 4.76926893 |
| 49 | negative regulation of protein activation cascade (GO:2000258) | 4.64558036 |
| 50 | negative regulation of blood coagulation (GO:0030195) | 4.64283601 |
| 51 | negative regulation of hemostasis (GO:1900047) | 4.64283601 |
| 52 | acute-phase response (GO:0006953) | 4.54710118 |
| 53 | cytolysis (GO:0019835) | 4.54376330 |
| 54 | glutamate metabolic process (GO:0006536) | 4.46114815 |
| 55 | alkaloid metabolic process (GO:0009820) | 4.41211320 |
| 56 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.39368432 |
| 57 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.35067174 |
| 58 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.35067174 |
| 59 | triglyceride homeostasis (GO:0070328) | 4.29876048 |
| 60 | acylglycerol homeostasis (GO:0055090) | 4.29876048 |
| 61 | indole-containing compound catabolic process (GO:0042436) | 4.23511454 |
| 62 | indolalkylamine catabolic process (GO:0046218) | 4.23511454 |
| 63 | tryptophan catabolic process (GO:0006569) | 4.23511454 |
| 64 | negative regulation of coagulation (GO:0050819) | 4.21260129 |
| 65 | negative regulation of wound healing (GO:0061045) | 4.17387975 |
| 66 | amino-acid betaine metabolic process (GO:0006577) | 4.16633779 |
| 67 | flavonoid metabolic process (GO:0009812) | 4.14700053 |
| 68 | alpha-amino acid catabolic process (GO:1901606) | 4.06288867 |
| 69 | protein-lipid complex remodeling (GO:0034368) | 4.01765285 |
| 70 | macromolecular complex remodeling (GO:0034367) | 4.01765285 |
| 71 | plasma lipoprotein particle remodeling (GO:0034369) | 4.01765285 |
| 72 | positive regulation of hemostasis (GO:1900048) | 3.96657645 |
| 73 | positive regulation of blood coagulation (GO:0030194) | 3.96657645 |
| 74 | aromatic amino acid family metabolic process (GO:0009072) | 3.94628252 |
| 75 | phospholipid efflux (GO:0033700) | 3.89974043 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 3.89911543 |
| 77 | hormone catabolic process (GO:0042447) | 3.89217206 |
| 78 | cholesterol efflux (GO:0033344) | 3.85968073 |
| 79 | arginine metabolic process (GO:0006525) | 3.79515372 |
| 80 | high-density lipoprotein particle remodeling (GO:0034375) | 3.76921789 |
| 81 | intestinal cholesterol absorption (GO:0030299) | 3.74688183 |
| 82 | response to mercury ion (GO:0046689) | 3.73792570 |
| 83 | sodium-independent organic anion transport (GO:0043252) | 3.66882225 |
| 84 | negative regulation of complement activation (GO:0045916) | 3.65964212 |
| 85 | cellular ketone body metabolic process (GO:0046950) | 3.65213039 |
| 86 | positive regulation of coagulation (GO:0050820) | 3.64218967 |
| 87 | xenobiotic metabolic process (GO:0006805) | 3.60645237 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.55847892 |
| 89 | tryptophan metabolic process (GO:0006568) | 3.54817989 |
| 90 | fat-soluble vitamin biosynthetic process (GO:0042362) | 3.50138059 |
| 91 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.47864239 |
| 92 | cellular amino acid catabolic process (GO:0009063) | 3.44296218 |
| 93 | reverse cholesterol transport (GO:0043691) | 3.43324230 |
| 94 | positive regulation of lipid catabolic process (GO:0050996) | 3.42947537 |
| 95 | regulation of cholesterol esterification (GO:0010872) | 3.38591861 |
| 96 | regulation of acute inflammatory response (GO:0002673) | 3.36919365 |
| 97 | heme transport (GO:0015886) | 3.36356254 |
| 98 | acute inflammatory response (GO:0002526) | 3.35476186 |
| 99 | exogenous drug catabolic process (GO:0042738) | 10.8542778 |
| 100 | omega-hydroxylase P450 pathway (GO:0097267) | 10.1080613 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.97981995 |
| 2 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.93725910 |
| 3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.85897841 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.84186344 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.70543871 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.69760222 |
| 7 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.33310334 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.20592616 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.98714966 |
| 10 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.52302371 |
| 11 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.15866750 |
| 12 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.07530036 |
| 13 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.06654205 |
| 14 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.4045053 |
| 15 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.94896453 |
| 16 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.92258738 |
| 17 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.48290693 |
| 18 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.43964537 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.41302144 |
| 20 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.39481778 |
| 21 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.33611620 |
| 22 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23250953 |
| 23 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.16842877 |
| 24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.01064046 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.00642164 |
| 26 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.99385947 |
| 27 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99246786 |
| 28 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.97262638 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.95470309 |
| 30 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.91488628 |
| 31 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.90778073 |
| 32 | CDX2_21074721_ChIP-Seq_CACO-2_Mouse | 0.90071100 |
| 33 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.89388956 |
| 34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.88705846 |
| 35 | CBP_21632823_ChIP-Seq_H3396_Human | 0.88698038 |
| 36 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87452292 |
| 37 | PHF8_20622853_ChIP-Seq_HELA_Human | 0.87083747 |
| 38 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.85526238 |
| 39 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.85180161 |
| 40 | GATA1_22025678_ChIP-Seq_K562_Human | 0.84315279 |
| 41 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.83938918 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.83564456 |
| 43 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.81879865 |
| 44 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.80271899 |
| 45 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.79940221 |
| 46 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.78270543 |
| 47 | NFYA_21822215_ChIP-Seq_K562_Human | 0.77958452 |
| 48 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.77249257 |
| 49 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.75637860 |
| 50 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.74708076 |
| 51 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.74001370 |
| 52 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.73897414 |
| 53 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.73777284 |
| 54 | AR_20517297_ChIP-Seq_VCAP_Human | 0.73422465 |
| 55 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.72213960 |
| 56 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.71906925 |
| 57 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.70697251 |
| 58 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.68846553 |
| 59 | SOX2_21211035_ChIP-Seq_LN229_Human | 0.64619150 |
| 60 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.64213553 |
| 61 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.63890226 |
| 62 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.62169349 |
| 63 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.61646139 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.60417191 |
| 65 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.59904561 |
| 66 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.59212919 |
| 67 | ETV1_20927104_ChIP-Seq_GIST48_Human | 0.59043693 |
| 68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.58674382 |
| 69 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.58279349 |
| 70 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.57529808 |
| 71 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.57427772 |
| 72 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.56697741 |
| 73 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.56697741 |
| 74 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.56570797 |
| 75 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.55546680 |
| 76 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.55226597 |
| 77 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.54832296 |
| 78 | NFYB_21822215_ChIP-Seq_K562_Human | 0.54332605 |
| 79 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.54302586 |
| 80 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.54076393 |
| 81 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.53239451 |
| 82 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.53066979 |
| 83 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.53027972 |
| 84 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.52801436 |
| 85 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.52104092 |
| 86 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.50571791 |
| 87 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.50305302 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.50207261 |
| 89 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.50077777 |
| 90 | PCGF4_22325352_ChIP-Seq_293T-Rex_Human | 0.48888045 |
| 91 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.48704482 |
| 92 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.48375870 |
| 93 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.47951592 |
| 94 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.47736221 |
| 95 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.47629395 |
| 96 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.47448379 |
| 97 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.47305319 |
| 98 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.46719333 |
| 99 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.46212406 |
| 100 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.46138082 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 9.90517742 |
| 2 | MP0005085_abnormal_gallbladder_physiolo | 6.47562021 |
| 3 | MP0005360_urolithiasis | 6.06346318 |
| 4 | MP0008875_abnormal_xenobiotic_pharmacok | 6.04840423 |
| 5 | MP0005365_abnormal_bile_salt | 5.77593432 |
| 6 | MP0003195_calcinosis | 4.91438173 |
| 7 | MP0003252_abnormal_bile_duct | 4.55324341 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 4.36603568 |
| 9 | MP0001666_abnormal_nutrient_absorption | 3.23471590 |
| 10 | MP0003868_abnormal_feces_composition | 2.91393337 |
| 11 | MP0010329_abnormal_lipoprotein_level | 2.82546184 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.45305890 |
| 13 | MP0005332_abnormal_amino_acid | 2.40845470 |
| 14 | MP0009697_abnormal_copulation | 2.38960665 |
| 15 | MP0003806_abnormal_nucleotide_metabolis | 2.19195355 |
| 16 | MP0010368_abnormal_lymphatic_system | 2.05744558 |
| 17 | MP0000609_abnormal_liver_physiology | 1.91394207 |
| 18 | MP0009840_abnormal_foam_cell | 1.82947493 |
| 19 | MP0002118_abnormal_lipid_homeostasis | 1.67836428 |
| 20 | MP0002876_abnormal_thyroid_physiology | 1.63145520 |
| 21 | MP0005670_abnormal_white_adipose | 1.56484257 |
| 22 | MP0001764_abnormal_homeostasis | 1.46763148 |
| 23 | MP0001661_extended_life_span | 1.40147912 |
| 24 | MP0009053_abnormal_anal_canal | 1.26330863 |
| 25 | MP0003656_abnormal_erythrocyte_physiolo | 1.17177156 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.16835656 |
| 27 | MP0002132_abnormal_respiratory_system | 1.16155960 |
| 28 | MP0005408_hypopigmentation | 1.16090318 |
| 29 | MP0005319_abnormal_enzyme/_coenzyme | 1.14996061 |
| 30 | MP0000598_abnormal_liver_morphology | 1.08644537 |
| 31 | MP0009764_decreased_sensitivity_to | 1.02216172 |
| 32 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.99874150 |
| 33 | MP0009643_abnormal_urine_homeostasis | 0.96947492 |
| 34 | MP0009763_increased_sensitivity_to | 0.92724237 |
| 35 | MP0005451_abnormal_body_composition | 0.91578952 |
| 36 | MP0002282_abnormal_trachea_morphology | 0.90922417 |
| 37 | MP0002971_abnormal_brown_adipose | 0.87263393 |
| 38 | MP0008469_abnormal_protein_level | 0.82511737 |
| 39 | MP0009642_abnormal_blood_homeostasis | 0.82201118 |
| 40 | MP0000604_amyloidosis | 0.80027876 |
| 41 | MP0008872_abnormal_physiological_respon | 0.78760912 |
| 42 | MP0001915_intracranial_hemorrhage | 0.78475755 |
| 43 | MP0005376_homeostasis/metabolism_phenot | 0.78212467 |
| 44 | MP0003690_abnormal_glial_cell | 0.74926888 |
| 45 | MP0005636_abnormal_mineral_homeostasis | 0.70652235 |
| 46 | MP0005187_abnormal_penis_morphology | 0.70580869 |
| 47 | MP0005535_abnormal_body_temperature | 0.70066060 |
| 48 | MP0002249_abnormal_larynx_morphology | 0.69830353 |
| 49 | MP0005395_other_phenotype | 0.69477543 |
| 50 | MP0003186_abnormal_redox_activity | 0.66741957 |
| 51 | MP0003879_abnormal_hair_cell | 0.64680267 |
| 52 | MP0002168_other_aberrant_phenotype | 0.64208693 |
| 53 | MP0005266_abnormal_metabolism | 0.62437045 |
| 54 | MP0005464_abnormal_platelet_physiology | 0.61844107 |
| 55 | MP0002078_abnormal_glucose_homeostasis | 0.58817323 |
| 56 | MP0005023_abnormal_wound_healing | 0.58022761 |
| 57 | MP0004130_abnormal_muscle_cell | 0.57799716 |
| 58 | MP0003011_delayed_dark_adaptation | 0.57460953 |
| 59 | MP0008874_decreased_physiological_sensi | 0.57279257 |
| 60 | MP0005334_abnormal_fat_pad | 0.56496097 |
| 61 | MP0009785_altered_susceptibility_to | 0.55223082 |
| 62 | MP0004782_abnormal_surfactant_physiolog | 0.54406443 |
| 63 | MP0009765_abnormal_xenobiotic_induced | 0.51369343 |
| 64 | MP0005166_decreased_susceptibility_to | 0.50120996 |
| 65 | MP0003638_abnormal_response/metabolism_ | 0.49182677 |
| 66 | MP0002332_abnormal_exercise_endurance | 0.41369298 |
| 67 | MP0003075_altered_response_to | 0.41339415 |
| 68 | MP0000467_abnormal_esophagus_morphology | 0.38466416 |
| 69 | MP0000249_abnormal_blood_vessel | 0.37463204 |
| 70 | MP0004883_abnormal_blood_vessel | 0.37013679 |
| 71 | MP0005448_abnormal_energy_balance | 0.36408933 |
| 72 | MP0005164_abnormal_response_to | 0.36002075 |
| 73 | MP0003705_abnormal_hypodermis_morpholog | 0.35906262 |
| 74 | MP0002136_abnormal_kidney_physiology | 0.34922026 |
| 75 | MP0006036_abnormal_mitochondrial_physio | 0.34225266 |
| 76 | MP0000566_synostosis | 0.30805186 |
| 77 | MP0005220_abnormal_exocrine_pancreas | 0.30572270 |
| 78 | MP0001851_eye_inflammation | 0.29096043 |
| 79 | MP0005647_abnormal_sex_gland | 0.28613161 |
| 80 | MP0005397_hematopoietic_system_phenotyp | 0.27481538 |
| 81 | MP0001545_abnormal_hematopoietic_system | 0.27481538 |
| 82 | MP0005666_abnormal_adipose_tissue | 0.27424938 |
| 83 | MP0009115_abnormal_fat_cell | 0.27298443 |
| 84 | MP0000639_abnormal_adrenal_gland | 0.27209049 |
| 85 | MP0003953_abnormal_hormone_level | 0.25375928 |
| 86 | MP0001845_abnormal_inflammatory_respons | 0.23963181 |
| 87 | MP0003718_maternal_effect | 0.23141243 |
| 88 | MP0001881_abnormal_mammary_gland | 0.22650188 |
| 89 | MP0001756_abnormal_urination | 0.21093328 |
| 90 | MP0002128_abnormal_blood_circulation | 0.20297665 |
| 91 | MP0008873_increased_physiological_sensi | 0.19783930 |
| 92 | MP0003436_decreased_susceptibility_to | 0.19438849 |
| 93 | MP0002928_abnormal_bile_duct | 0.18789661 |
| 94 | MP0005058_abnormal_lysosome_morphology | 0.17625286 |
| 95 | MP0003959_abnormal_lean_body | 0.17374940 |
| 96 | MP0003632_abnormal_nervous_system | 0.17011275 |
| 97 | MP0005083_abnormal_biliary_tract | 0.16688090 |
| 98 | MP0010155_abnormal_intestine_physiology | 0.16347134 |
| 99 | MP0000920_abnormal_myelination | 0.15367461 |
| 100 | MP0005197_abnormal_uvea_morphology | 0.15212542 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 9.15102373 |
| 2 | Prolonged partial thromboplastin time (HP:0003645) | 8.80763499 |
| 3 | Abnormality of complement system (HP:0005339) | 8.55370812 |
| 4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 8.54564462 |
| 5 | Conjugated hyperbilirubinemia (HP:0002908) | 8.17135115 |
| 6 | Hypobetalipoproteinemia (HP:0003563) | 7.58256334 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 6.24237772 |
| 8 | Joint hemorrhage (HP:0005261) | 6.12891412 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.79592998 |
| 10 | Glomerulonephritis (HP:0000099) | 5.77395837 |
| 11 | Intrahepatic cholestasis (HP:0001406) | 5.68413400 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.93965361 |
| 13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.80849837 |
| 14 | Abnormality of pyrimidine metabolism (HP:0004353) | 4.80085411 |
| 15 | Xanthomatosis (HP:0000991) | 4.73871598 |
| 16 | Spontaneous abortion (HP:0005268) | 4.60888759 |
| 17 | Hypolipoproteinemia (HP:0010981) | 4.41566164 |
| 18 | Nephritis (HP:0000123) | 4.21885468 |
| 19 | Abnormality of the intrinsic pathway (HP:0010989) | 4.21453457 |
| 20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.89640809 |
| 21 | Fat malabsorption (HP:0002630) | 3.58062002 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.52973342 |
| 23 | Hypoalphalipoproteinemia (HP:0003233) | 3.47258071 |
| 24 | Abnormality of methionine metabolism (HP:0010901) | 3.44792189 |
| 25 | Hyperglycinemia (HP:0002154) | 3.12418930 |
| 26 | Hyperammonemia (HP:0001987) | 3.09510968 |
| 27 | Gingival bleeding (HP:0000225) | 3.05979278 |
| 28 | Neonatal hypoglycemia (HP:0001998) | 3.04835425 |
| 29 | Hypercholesterolemia (HP:0003124) | 2.96192351 |
| 30 | Mitral stenosis (HP:0001718) | 2.94714763 |
| 31 | Delayed CNS myelination (HP:0002188) | 2.84348263 |
| 32 | Fair hair (HP:0002286) | 2.83642442 |
| 33 | Generalized aminoaciduria (HP:0002909) | 2.81962935 |
| 34 | Hyperbilirubinemia (HP:0002904) | 2.81330018 |
| 35 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.76289101 |
| 36 | Abnormality of glycine metabolism (HP:0010895) | 2.76289101 |
| 37 | Vascular calcification (HP:0004934) | 2.75426015 |
| 38 | Thrombophlebitis (HP:0004418) | 2.68505187 |
| 39 | Hemorrhage of the eye (HP:0011885) | 2.67416661 |
| 40 | Epidermoid cyst (HP:0200040) | 2.66580003 |
| 41 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.66102029 |
| 42 | Rickets (HP:0002748) | 2.65568879 |
| 43 | Hepatocellular carcinoma (HP:0001402) | 2.65156239 |
| 44 | Abnormality of nucleobase metabolism (HP:0010932) | 2.64958378 |
| 45 | Osteomalacia (HP:0002749) | 2.63836792 |
| 46 | Steatorrhea (HP:0002570) | 2.55530268 |
| 47 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.46432528 |
| 48 | Cardiovascular calcification (HP:0011915) | 2.44939010 |
| 49 | Abnormality of serum amino acid levels (HP:0003112) | 2.42799329 |
| 50 | Purpura (HP:0000979) | 2.36862526 |
| 51 | Hyperglycinuria (HP:0003108) | 2.34655518 |
| 52 | Cholelithiasis (HP:0001081) | 2.31459755 |
| 53 | Pulmonary embolism (HP:0002204) | 2.26212228 |
| 54 | Abnormal gallbladder morphology (HP:0012437) | 2.15516876 |
| 55 | Menorrhagia (HP:0000132) | 2.12690462 |
| 56 | Elevated alkaline phosphatase (HP:0003155) | 2.08383342 |
| 57 | Joint swelling (HP:0001386) | 2.03243821 |
| 58 | Metabolic acidosis (HP:0001942) | 2.00683880 |
| 59 | Generalized hypopigmentation of hair (HP:0011358) | 2.00062440 |
| 60 | Complement deficiency (HP:0004431) | 10.5910665 |
| 61 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 10.3234149 |
| 62 | Abnormality of vitamin metabolism (HP:0100508) | 1.98386357 |
| 63 | Myocardial infarction (HP:0001658) | 1.95262925 |
| 64 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.93365241 |
| 65 | Ketosis (HP:0001946) | 1.93287556 |
| 66 | Hyperphosphaturia (HP:0003109) | 1.93055792 |
| 67 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.88419159 |
| 68 | Abnormal gallbladder physiology (HP:0012438) | 1.84840888 |
| 69 | Cholecystitis (HP:0001082) | 1.84840888 |
| 70 | Arthropathy (HP:0003040) | 1.83495196 |
| 71 | Increased mean platelet volume (HP:0011877) | 1.80986398 |
| 72 | Irritability (HP:0000737) | 1.80655451 |
| 73 | Blue irides (HP:0000635) | 1.79700248 |
| 74 | Abnormality of iron homeostasis (HP:0011031) | 1.77936400 |
| 75 | Increased serum ferritin (HP:0003281) | 1.77016381 |
| 76 | Abnormality of the Achilles tendon (HP:0005109) | 1.75179095 |
| 77 | Epistaxis (HP:0000421) | 1.74428827 |
| 78 | Bifid scrotum (HP:0000048) | 1.74402637 |
| 79 | Hypophosphatemic rickets (HP:0004912) | 1.74141245 |
| 80 | Abnormality of urine glucose concentration (HP:0011016) | 1.73641860 |
| 81 | Glycosuria (HP:0003076) | 1.73641860 |
| 82 | Reduced antithrombin III activity (HP:0001976) | 1.69590396 |
| 83 | Hypochromic microcytic anemia (HP:0004840) | 1.69431192 |
| 84 | Poikilocytosis (HP:0004447) | 1.67321417 |
| 85 | Cerebral palsy (HP:0100021) | 1.67219878 |
| 86 | Abnormality of purine metabolism (HP:0004352) | 1.66358488 |
| 87 | Skin nodule (HP:0200036) | 1.66099036 |
| 88 | Abnormal platelet volume (HP:0011876) | 1.64042529 |
| 89 | Gangrene (HP:0100758) | 1.63743122 |
| 90 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.62834551 |
| 91 | Abnormal urine phosphate concentration (HP:0012599) | 1.55943722 |
| 92 | Hydroxyprolinuria (HP:0003080) | 1.55869086 |
| 93 | Abnormality of proline metabolism (HP:0010907) | 1.55869086 |
| 94 | Abnormality of the gallbladder (HP:0005264) | 1.53612898 |
| 95 | Gout (HP:0001997) | 1.52578012 |
| 96 | Abnormal biliary tract physiology (HP:0012439) | 1.50585131 |
| 97 | Bile duct proliferation (HP:0001408) | 1.50585131 |
| 98 | Reticulocytosis (HP:0001923) | 1.48275527 |
| 99 | Alkalosis (HP:0001948) | 1.47971716 |
| 100 | Abnormal delivery (HP:0001787) | 1.47959404 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 5.52655523 |
| 2 | PIK3CG | 4.09076857 |
| 3 | FGFR4 | 3.95918014 |
| 4 | SIK1 | 3.26109534 |
| 5 | RIPK1 | 2.95258533 |
| 6 | TRIB3 | 2.94932843 |
| 7 | TYK2 | 2.80816732 |
| 8 | EPHA3 | 2.60458313 |
| 9 | PIK3CA | 2.32549483 |
| 10 | PRKACG | 2.23830958 |
| 11 | PRKAA2 | 2.06109943 |
| 12 | BCKDK | 1.94225682 |
| 13 | FGFR3 | 1.88765761 |
| 14 | PRPF4B | 1.86895554 |
| 15 | MAP2K4 | 1.78212489 |
| 16 | AKT3 | 1.74555438 |
| 17 | MAPK11 | 1.73157987 |
| 18 | TNK2 | 1.69766831 |
| 19 | MST1R | 1.65137043 |
| 20 | TAOK3 | 1.63617023 |
| 21 | JAK1 | 1.57226617 |
| 22 | NTRK3 | 1.56789216 |
| 23 | FER | 1.56731099 |
| 24 | NLK | 1.48236526 |
| 25 | NEK9 | 1.47403666 |
| 26 | IGF1R | 1.43313157 |
| 27 | MAP3K3 | 1.30669392 |
| 28 | MAP3K2 | 1.28369489 |
| 29 | ICK | 1.25232264 |
| 30 | ERBB2 | 1.22183766 |
| 31 | PDPK1 | 1.20071604 |
| 32 | EPHB1 | 1.19962031 |
| 33 | TBK1 | 1.15878369 |
| 34 | PRKCG | 1.13556473 |
| 35 | CAMKK2 | 1.11335476 |
| 36 | ABL2 | 1.08714510 |
| 37 | JAK2 | 1.05364857 |
| 38 | CSF1R | 0.96779259 |
| 39 | PRKCZ | 0.96446147 |
| 40 | MAP3K1 | 0.91646574 |
| 41 | KDR | 0.90150795 |
| 42 | PRKAA1 | 0.90025593 |
| 43 | RET | 0.89778141 |
| 44 | PRKG1 | 0.87685384 |
| 45 | PDK1 | 0.85251245 |
| 46 | TIE1 | 0.81895101 |
| 47 | PRKACA | 0.79359190 |
| 48 | MYLK | 0.79080600 |
| 49 | CDK6 | 0.76980617 |
| 50 | MET | 0.76119668 |
| 51 | SCYL2 | 0.70895194 |
| 52 | MAPK7 | 0.70230006 |
| 53 | EPHA4 | 0.68411752 |
| 54 | SGK3 | 0.68189393 |
| 55 | CAMK1D | 0.66857297 |
| 56 | DYRK1B | 0.66652200 |
| 57 | IRAK3 | 0.66325313 |
| 58 | PKN2 | 0.65243812 |
| 59 | ZAP70 | 0.64565099 |
| 60 | SGK2 | 0.62582046 |
| 61 | INSRR | 0.62381545 |
| 62 | MAP3K6 | 0.62085903 |
| 63 | BRSK2 | 0.60106277 |
| 64 | MAPK12 | 0.59448969 |
| 65 | MAPK4 | 0.58418849 |
| 66 | ERBB4 | 0.57959390 |
| 67 | TGFBR2 | 0.57379805 |
| 68 | SGK223 | 0.57258138 |
| 69 | SGK494 | 0.57258138 |
| 70 | DAPK2 | 0.54174025 |
| 71 | RPS6KA3 | 0.53950192 |
| 72 | KSR2 | 0.52646561 |
| 73 | PDK2 | 0.52643312 |
| 74 | CSNK1E | 0.51906330 |
| 75 | PINK1 | 0.51703589 |
| 76 | PRKCB | 0.51336039 |
| 77 | CSNK1D | 0.51312886 |
| 78 | STK38 | 0.51305081 |
| 79 | PRKCA | 0.50702711 |
| 80 | SRC | 0.49315537 |
| 81 | BLK | 0.48653724 |
| 82 | MAP3K11 | 0.46609375 |
| 83 | CAMKK1 | 0.46077370 |
| 84 | MAP3K13 | 0.45614667 |
| 85 | PRKACB | 0.44479770 |
| 86 | MTOR | 0.42479098 |
| 87 | PTK6 | 0.41622369 |
| 88 | GSK3A | 0.40213446 |
| 89 | FRK | 0.40107251 |
| 90 | IKBKE | 0.40082318 |
| 91 | PDGFRA | 0.39973389 |
| 92 | SGK1 | 0.38631087 |
| 93 | KIT | 0.38427700 |
| 94 | TAOK2 | 0.35616939 |
| 95 | MAPK3 | 0.31955315 |
| 96 | CSNK2A1 | 0.31853060 |
| 97 | CAMK2G | 0.30061212 |
| 98 | SMG1 | 0.28914869 |
| 99 | GRK1 | 0.27479119 |
| 100 | FGFR2 | 0.26526732 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.54299258 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 4.50146056 |
| 3 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 3.88225425 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 3.58887685 |
| 5 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.57496134 |
| 6 | Retinol metabolism_Homo sapiens_hsa00830 | 3.51304688 |
| 7 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.49387059 |
| 8 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.98153393 |
| 9 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.96679445 |
| 10 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.68836672 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.60596516 |
| 12 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 2.57538968 |
| 13 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.55278426 |
| 14 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.52354117 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51842214 |
| 16 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.47946132 |
| 17 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.46530025 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.05419116 |
| 19 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.97111761 |
| 20 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.95724154 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.87594756 |
| 22 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.86185648 |
| 23 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.82269462 |
| 24 | Bile secretion_Homo sapiens_hsa04976 | 1.73949709 |
| 25 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.58029440 |
| 26 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.43732742 |
| 27 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.43471373 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.42906200 |
| 29 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.42377556 |
| 30 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.38290084 |
| 31 | Prion diseases_Homo sapiens_hsa05020 | 1.37358989 |
| 32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.31253574 |
| 33 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.30939560 |
| 34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.27607002 |
| 35 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.18500290 |
| 36 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.17345669 |
| 37 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.11716320 |
| 38 | Peroxisome_Homo sapiens_hsa04146 | 1.10858613 |
| 39 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.08807444 |
| 40 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.98092706 |
| 41 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.97243019 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 0.90111821 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.88984363 |
| 44 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.87129357 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.83974871 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82737634 |
| 47 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.82112829 |
| 48 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.81196664 |
| 49 | Carbon metabolism_Homo sapiens_hsa01200 | 0.78032230 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.77318198 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.71843489 |
| 52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.71231926 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66642219 |
| 54 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.58694473 |
| 55 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52744209 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.41471675 |
| 57 | Metabolic pathways_Homo sapiens_hsa01100 | 0.39024934 |
| 58 | Pertussis_Homo sapiens_hsa05133 | 0.34804349 |
| 59 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.27840045 |
| 60 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.27203657 |
| 61 | Insulin resistance_Homo sapiens_hsa04931 | 0.26573149 |
| 62 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.25774846 |
| 63 | Sulfur relay system_Homo sapiens_hsa04122 | 0.19559592 |
| 64 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.18162010 |
| 65 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.17975692 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.15589807 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.15349939 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.13207357 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.12033563 |
| 70 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.11030986 |
| 71 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.04060928 |
| 72 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.03940200 |
| 73 | Amoebiasis_Homo sapiens_hsa05146 | 0.02225812 |
| 74 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.01572030 |
| 75 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.00498316 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.2883869 |
| 77 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.2869802 |
| 78 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.2773493 |
| 79 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.2700706 |
| 80 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.2524055 |
| 81 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2408195 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | -0.2335615 |
| 83 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.2234818 |
| 84 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | -0.2077953 |
| 85 | Circadian rhythm_Homo sapiens_hsa04710 | -0.1956015 |
| 86 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | -0.1560110 |
| 87 | Nitrogen metabolism_Homo sapiens_hsa00910 | -0.1475827 |
| 88 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1278529 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1200129 |
| 90 | Steroid biosynthesis_Homo sapiens_hsa00100 | -0.1109262 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.0791225 |
| 92 | Other glycan degradation_Homo sapiens_hsa00511 | -0.0742281 |
| 93 | Folate biosynthesis_Homo sapiens_hsa00790 | -0.0651115 |
| 94 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0349546 |
| 95 | Galactose metabolism_Homo sapiens_hsa00052 | -0.0307031 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0300631 |
| 97 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0211609 |
| 98 | Glutathione metabolism_Homo sapiens_hsa00480 | -0.0180825 |
| 99 | Mineral absorption_Homo sapiens_hsa04978 | -0.0088600 |
| 100 | Serotonergic synapse_Homo sapiens_hsa04726 | -0.0005334 |

